|
MRPL41 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64379954092908E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.29305504876265E-13 |
| Normal-vs-Stage2 |
2.453800E-01 |
| Normal-vs-Stage3 |
7.2560000008437E-08 |
| Normal-vs-Stage4 |
4.433500E-04 |
| Stage1-vs-Stage2 |
8.514300E-02 |
| Stage1-vs-Stage3 |
1.458190E-01 |
| Stage1-vs-Stage4 |
6.531700E-02 |
| Stage2-vs-Stage3 |
2.330600E-01 |
| Stage2-vs-Stage4 |
4.542200E-01 |
| Stage3-vs-Stage4 |
4.508200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.30377996866127E-12 |
| Normal-vs-AfricanAmerican |
4.664600E-01 |
| Normal-vs-Asian |
9.361300E-03 |
| Caucasian-vs-AfricanAmerican |
2.384800E-03 |
| Caucasian-vs-Asian |
9.998000E-01 |
| AfricanAmerican-vs-Asian |
2.346200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.79119949375684E-10 |
| Normal-vs-Female |
4.52120000327128E-08 |
| Male-vs-Female |
4.012400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.823000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.58990051626995E-10 |
| Normal-vs-Age(61-80Yrs) |
5.05050001819995E-10 |
| Normal-vs-Age(81-100Yrs) |
9.474200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.307200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.450600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.841800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.160600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.978200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.084600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.04369999999843E-05 |
| Normal-vs-Grade 2 |
5.86529713686446E-11 |
| Normal-vs-Grade 3 |
1.03680000140827E-08 |
| Normal-vs-Grade 4 |
3.098400E-03 |
| Grade 1-vs-Grade 2 |
4.120600E-01 |
| Grade 1-vs-Grade 3 |
1.064600E-01 |
| Grade 1-vs-Grade 4 |
4.150200E-02 |
| Grade 2-vs-Grade 3 |
1.671030E-01 |
| Grade 2-vs-Grade 4 |
5.930400E-02 |
| Grade 3-vs-Grade 4 |
3.270600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
8.34400000204738E-08 |
| ccA subtype-vs-ccB subtype |
6.364500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21479962042781E-10 |
| Normal-vs-N1 |
4.342400E-01 |
| N0-vs-N1 |
1.155010E-01 |
|
|
